Differential effects of everolimus and cyclosporine A on intimal α-actin-positive cell dynamics of carotid allografts in mice

Transplantation

Volumn 78, Issue 3, 2004, Pages 345-351

  Matsumoto, Yuji ^a,b   Hof, Akiko ^a   Baumlin, Yves ^a   Müller, Matthias ^a   Hof, Robert P ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell origin; Cyclosporine A; Everolimus; Smooth muscle cells; Transplant atherosclerosis

Indexed keywords

ALPHA ACTIN; CYCLOSPORIN A; EVEROLIMUS; GREEN FLUORESCENT PROTEIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ACTINS; ANIMALS; CAROTID ARTERIES; CYCLOSPORINE; GREEN FLUORESCENT PROTEINS; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; SIROLIMUS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA;

EID: 4143124473     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000128610.93598.80     Document Type: Article

References (29)

1. Häyry P, Mennander A, Yilmaz S, et al. Towards understanding the pathophysiology of chronic rejection. Clin Invest 1992; 70: 780.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801.
3. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387.
4. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115.
5. Li J, Han X, Jiang J, et al. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am J Pathol 2001; 158: 1943.
6. Hillebrands JL, Klatter FA, van den Hurk BM, et al. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001; 107: 1411.
7. Saiura A, Sata M, Hirata Y, et al. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001; 7: 382.
8. Shimizu K, Sugiyama S, Aikawa M, et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001; 7: 738.
9. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403.
10. Matsumoto Y, Hof A, Baumlin Y, et al. Dynamics of medial smooth muscle changes after carotid artery transplantation in transgenic mice expressing green fluorescent protein. Transplantation 2003; 76: 1569.
11. Schuler W, Sedrani R, Cottens S, et al. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation 1997; 64: 36.
12. Wehr S, Rudin M, Joergensen J, et al. Allo- and autotransplantation of carotid artery: a new model of chronic graft vessel disease: evaluation by magnetic resonance imaging and histology. Transplantation 1997; 64: 20.
13. Nikolova Z, Hof A, Baumlin Y, et al. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Transpl Immunol 2000; 8: 115.
14. Matsumoto Y, Hof A, Baumlin Y, et al. Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid allografts in apolipoprotein E-deficient mice. Transplantation 2003; 76: 1166.
15. Nikolova Z, Hof A, Baumlin Y, et al. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model. Transplantation 2001; 72: 168.
16. Nikolova Z, Hof A, Baumlin Y, et al. Efficacy of SDZ RAD compared with CsA monotherapy and combined RAD/FTY720 treatment in a murine cardiac allotransplantation model. Transpl Immunol 2001; 9: 43.
17. Nikolova Z, Hof A, Rudin M, et al. Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation 2000; 69: 2525.
18. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
19. Nikolova Z, Hof A, Baumlin Y, et al. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Transpl Immunol 2001; 8: 267.
20. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349: 847.
21. Bayes-Genis A, Campbell JH, Carlson PJ, et al. Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair. Atherosclerosis 2002; 163: 89.
22. Campbell JH, Efendy JL, Han C, et al. Haemopoietic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body. J Vasc Res 2000; 37: 364.
23. Andersen HO, Hansen BF, Holm P, et al. Effect of cyclosporine on arterial balloon injury lesions in cholesterol-clamped rabbits: T lymphocyte-mediated immune responses not involved in balloon injury-induced neointimal proliferation. Arterioscler Thromb Vasc Biol 1999; 19: 1687.
24. Hu Y, Davison F, Ludewig B, et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002; 106: 1834.
25. Krupnick AS, Kreisel D, Popma SH, et al. Mechanism of T cell-mediated endothelial apoptosis. Transplantation 2002; 74: 871.
26. Bojakowski K, Religa P, Bojakowska M, et al. Arteriosclerosis in rat aortic allografts: early changes in endothelial integrity and smooth muscle phenotype. Transplantation 2000; 70: 65.
27. Farb A, John M, Acampado E, et alR. Oral everolimus inhibits in-stent neointimal growth. Circulation 2002; 106: 2379.
28. Gallo R, Padurean A, Jayaraman T, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999; 99: 2164.
29. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773.